参考文献/References:
[1]Roshangar L,Soleimani Rad J,Kheirjou R,et al.Skin Burns: Review of Molecular Mechanisms and Therapeutic Approaches[J].Wounds,2019,31(12):308-315.[2]梁娜娜,薛喜娟,刘晓慧,等.烧伤患者照顾者生活质量及其影响因素[J].河南医学研究,2021,30(31):5769-5773.[3]Barnes LA,Marshall CD,Leavitt T,et al.Mechanical Forces in Cutaneous Wound Healing: Emerging Therapies to Minimize Scar Formation[J].Adv Wound Care (New Rochelle),2018,7(2):47-56.[4]Savoji H,Godau B,Hassani MS,et al.Skin Tissue Substitutes and Biomaterial Risk Assessment and Testing[J].Front Bioeng Biotechnol,2018,6:86.[5]Gibson ALF,Carney BC,Cuttle L,et al.Coming to Consensus: What Defines Deep Partial Thickness Burn Injuries in Porcine Models?[J].J Burn Care Res,2021,42(1):98-109.[6]Zhang M,Li H,Zhang Y,et al.Oncogenic miR-744 promotes prostate cancer growth through direct targeting of LKB1[J].Oncol Lett,2019,17(2):2257-2265.[7]Kang W,Huang T,Zhou Y,et al.miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis[J].Cell Death Dis,2018,9(2):92. [8]Moody SE,Schinzel AC,Singh S,et al.PRKACA mediates resistance to HER2-targeted therapy in breast cancer cells and restores anti-apoptotic signaling[J].Oncogene,2015,34(16):2061-2071.[9]Jimenez-Pascual A,Mitchell K,Siebzehnrubl FA,et al.FGF2:a novel druggable target for glioblastoma?[J].Expert Opin Ther Targets,2020,24(4):311-318.[10]胡雅琼,白俊,陈琳,等.miR-625-5p通过靶向调控PRKACA促进肺腺癌细胞的增殖和侵袭[J].中国癌症杂志,2021,31(6):447-454.[11]Yu W,Chen PB,Chen FC,et al.MicroRNA-744 promotes proliferation of osteosarcoma cells by targeting PTEN[J].Mol Med Rep,2020,21(5):2276-2282.[12]Ahn HN,Kang HS,Park SJ,et al.Safety and efficacy of basic fibroblast growth factors for deep second-degree burn patients[J].Burns,2020,46(8):1857-1866.